The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AbbVie Inc | COM | 00287Y109 | 3,643 | 61,500 | SH | SOLE | 0 | 61,500 | 0 | 0 | |
| Advanced Accelerator Applic | SPONSORED ADS | 00790T100 | 235 | 7,500 | SH | SOLE | 0 | 7,500 | 0 | 0 | |
| Advaxis Inc | COM NEW | 007624208 | 556 | 55,264 | SH | SOLE | 0 | 55,264 | 0 | 0 | |
| Aerie Pharmaceuticals Inc | COM | 00771V108 | 688 | 28,240 | SH | SOLE | 0 | 28,240 | 0 | 0 | |
| Alder Biopharmaceuticals Inc | COM | 014339105 | 1,982 | 60,000 | SH | SOLE | 0 | 60,000 | 0 | 0 | |
| Allergan PLC | SHS | G0177J108 | 2,875 | 9,200 | SH | SOLE | 0 | 9,200 | 0 | 0 | |
| Bristol Myers Squibb Co | COM | 110122108 | 10,043 | 146,000 | SH | SOLE | 0 | 146,000 | 0 | 0 | |
| Celator Pharmaceuticals Inc | COM | 15089R102 | 158 | 90,000 | SH | SOLE | 0 | 90,000 | 0 | 0 | |
| Celgene Corp | COM | 151020104 | 9,581 | 80,000 | SH | SOLE | 0 | 80,000 | 0 | 0 | |
| Cerulean Pharma Inc | COM | 15708Q105 | 140 | 50,000 | SH | SOLE | 0 | 50,000 | 0 | 0 | |
| Concert Pharmaceuticals Inc | COM | 206022105 | 3,472 | 183,000 | SH | SOLE | 0 | 183,000 | 0 | 0 | |
| CTI BioPharma Corp | COM | 12648L106 | 807 | 656,000 | SH | SOLE | 0 | 656,000 | 0 | 0 | |
| Durect Corp | COM | 266605104 | 622 | 281,514 | SH | SOLE | 0 | 281,514 | 0 | 0 | |
| Fibrocell Science Inc | COM NEW | 315721209 | 137 | 30,000 | SH | SOLE | 0 | 30,000 | 0 | 0 | |
| Five Prime Therapeutics Inc | COM | 33830X104 | 892 | 21,500 | SH | SOLE | 0 | 21,500 | 0 | 0 | |
| GenVec Inc | COM NEW | 37246C307 | 35 | 19,097 | SH | SOLE | 0 | 19,097 | 0 | 0 | |
| GW Pharmaceuticals PLC | ADS | 36197T103 | 347 | 5,000 | SH | SOLE | 0 | 5,000 | 0 | 0 | |
| Heron Therapeutics Inc | COM | 427746102 | 630 | 23,600 | SH | SOLE | 0 | 23,600 | 0 | 0 | |
| Horizon Pharma PLC | SHS | G4617B105 | 3,120 | 144,000 | SH | SOLE | 0 | 144,000 | 0 | 0 | |
| Immune Design Corp | COM | 45252L103 | 803 | 40,000 | SH | SOLE | 0 | 40,000 | 0 | 0 | |
| Inotek Pharmaceuticals Corp | COM | 45780V102 | 476 | 42,000 | SH | SOLE | 0 | 42,000 | 0 | 0 | |
| Inovio Pharmaceuticals Inc | COM NEW | 45773H201 | 403 | 60,000 | SH | SOLE | 0 | 60,000 | 0 | 0 | |
| Kamada Ltd | SHS | M6240T109 | 302 | 72,000 | SH | SOLE | 0 | 72,000 | 0 | 0 | |
| Lion Biotechnologies Inc | COM | 53619R102 | 1,175 | 152,266 | SH | SOLE | 0 | 152,266 | 0 | 0 | |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | 191 | 25,000 | SH | SOLE | 0 | 25,000 | 0 | 0 | |
| Merck & Co Inc New | COM | 58933Y105 | 5,493 | 104,000 | SH | SOLE | 0 | 104,000 | 0 | 0 | |
| Merrimack Pharmaceuticals In | COM | 590328100 | 284 | 36,000 | SH | SOLE | 0 | 36,000 | 0 | 0 | |
| Minerva Neurosciences Inc | COM | 603380106 | 207 | 34,100 | SH | SOLE | 0 | 34,100 | 0 | 0 | |
| Neos Therapeutics Inc | COM | 64052L106 | 215 | 15,000 | SH | SOLE | 0 | 15,000 | 0 | 0 | |
| Neurocrine Biosciences Inc | COM | 64125C109 | 1,527 | 27,000 | SH | SOLE | 0 | 27,000 | 0 | 0 | |
| Neuroderm Ltd | ORD SHS | M74231107 | 818 | 48,000 | SH | SOLE | 0 | 48,000 | 0 | 0 | |
| Oncothyreon Inc | COM | 682324108 | 444 | 200,000 | SH | SOLE | 0 | 200,000 | 0 | 0 | |
| Peregrine Pharmaceuticals In | COM NEW | 713661304 | 287 | 245,000 | SH | SOLE | 0 | 245,000 | 0 | 0 | |
| Pfizer Inc | COM | 717081103 | 10,652 | 330,000 | SH | SOLE | 0 | 330,000 | 0 | 0 | |
| Pronai Therapeutics Inc | COM | 74346L101 | 301 | 20,000 | SH | SOLE | 0 | 20,000 | 0 | 0 | |
| Redhill Biopharma Ltd | SPONSORED ADS | 757468103 | 309 | 24,000 | SH | SOLE | 0 | 24,000 | 0 | 0 | |
| SciClone Pharmaceuticals Inc | COM | 80862K104 | 598 | 65,000 | SH | SOLE | 0 | 65,000 | 0 | 0 | |
| SCYNEXIS Inc | COM | 811292101 | 246 | 39,693 | SH | SOLE | 0 | 39,693 | 0 | 0 | |
| Seattle Genetics Inc | COM | 812578102 | 4,039 | 90,000 | SH | SOLE | 0 | 90,000 | 0 | 0 | |
| TetraLogic Pharmaceuticals C | COM | 88165U109 | 111 | 64,000 | SH | SOLE | 0 | 64,000 | 0 | 0 | |
| Tobira Therapeutics Inc | COM | 88883P101 | 352 | 35,000 | SH | SOLE | 0 | 35,000 | 0 | 0 | |
| uniQure NV | SHS | N90064101 | 595 | 36,000 | SH | SOLE | 0 | 36,000 | 0 | 0 | |
| Vascular Biogenics Ltd | COM | M96883109 | 175 | 33,332 | SH | SOLE | 0 | 33,332 | 0 | 0 | |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | 375 | 20,720 | SH | SOLE | 0 | 20,720 | 0 | 0 | |
| Zynerba Pharmaceuticals Inc | COM | 98986X109 | 151 | 15,000 | SH | SOLE | 0 | 15,000 | 0 | 0 | |